|
|
| Research article summary (published 30 Dec 2005): |
[Megakaryopoietic cytokine levels in patients with essential thrombocythemia and their relationship with clinical and biochemical features]
(Niveles de citoquinas megacariocitopoyeticas en pacientes con trombocitemia esencial y su relacion con caracteristicas clinicas y bioquimicas.)
Full Abstract
Megakaryopoiesis and platelet production are driven by transcription factors and cytokines present in bone marrow environment. Essential thrombocythemia (ET) is a chronic myeloproliferative disorder characterized by high platelet count and megakaryocytic hyperplasia. In the present work we evaluated plasmatic levels of cytokines involved in megakaryocytic development in a group of patients with ET that were not on treatment, as well as thrombopoietin (TPO) levels before and during anagrelide treatment. The assays were carried out using ELISA techniques. Among the cytokines mainly involved in proliferation of megakaryocytic progenitors, interleukin 3 (IL-3) levels were found increased in patients compared to normal controls (p = 0.0383). Granulocyte-macrophage colony stimulating factor and stem cell factor levels were normal. Interleukin 6, as well as interleukin 11 and erythropoietin (EPO), cytokines mainly related to megakaryocytic maturation, were normal. Plasma TPO levels before treatment were within the normal range and increased during treatment but the difference was not statistically significant. Patients who displayed spontaneous platelet aggregation had higher plasma TPO levels compared to those who did not (p = 0.049). We did not find any relationship between cytokine levels and clinical or laboratory parameters. The high IL-3 levels seen in some patients with ET could contribute to megakaryocytic proliferation. The simultaneous occurrence of higher TPO levels and elevated platelet count could be a predisposing factor for the development of spontaneous platelet aggregation in ET patients.
Learn Faster Today Improve your study skills
Author information
Author/s: Marta, Rosana F (RF); Goette, Nora P (NP); Molinas, Felisa C (FC);
Affiliation: Sección Hematología Investigación, Instituto de Investigaciones Médicas Alfredo Lanari, Facultad de Medicina, Universidad de Buenos Aires, Argentina. rfmarta(-atsign-)ciudad.com.ar
Journal and publication information
Publication Type: Controlled Clinical Trial; English Abstract; Journal Article
Journal: Medicina (Medicina (B Aires)), published in Argentina. (Language: spa)
Reference: 2006-; vol 66 (issue 6) : pp 540-6
Dates: Created 2007/01/23; Completed 2007/08/16; Revised 2008/11/21;
PMID: 17240625, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Primary and secondary thrombocytosis in childhood.
30 Mar 2005 - The clinical spectrum of thrombocytosis and thrombocythemia.
30 Dec 1990 - Reactive and clonal thrombocytosis: proinflammatory and hematopoietic cytokines and acute phase proteins.
30 Mar 2001 - Treatment of essential thrombocythemia with anagrelide.
30 Aug 1995 - [Anagrelide in control of myeloproliferative thrombocythemia: long-term experiences in 6 patients]
12 Nov 1998 - Essential thrombocythemia in young adults.
30 Jan 1991 - GpIIb/IIIa+ subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin.
30 Jul 1996 - Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis.
29 Sep 1999 - Early suppressive effects of chemotherapy on recovery of bone marrow megakaryocyte precursors: possible relationship to platelet recovery.
30 Dec 1995 - Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood.
30 Mar 2003
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.